Clinical Trials · NCT04224818

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
American University of Beirut Medical Center
Enrollment
140
Start date
Jul 2018
Locations
1 site, Lebanon
Primary endpoint
Number of oocytes retrieved (oocyte collection rate)
View Gonadorelin compound reference